drugset / Trial / NCT06859892

Dexmedetomidine-Esketamine Combination and Sleep Disturbances After Major Noncardiac Surgery

NCT06859892

Phase 4 Recruiting 476 enrolled Peking University First Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Sleep disturbances are common early after major surgery, and are associated with delayed recovery. A previous study showed that dexmedetomidine-esketamine combination as a supplement to patient-controlled intravenous analgesia improved postoperative analgesia and subjective sleep quality in patients after scoliosis correction surgery. The purpose of this trial is to test the hypothesis that dexmedetomidine-esketamine combination used as a supplement during general anesthesia and postoperative intravenous analgesia may reduce sleep disturbances in adult after major noncardiac surgery.

Timeline

Start
2025-03-18
Primary completion
2026-11
Completion
2026-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg Intravenous
Subject Esketamine Other / unclassified 0.1 mg/kg Intravenous
Background Sufentanil Other / unclassified 100 ug Intravenous

Indications